MENU
+Compare
MKGAF
Stock ticker: OTC
AS OF
Sep 5 closing price
Price
$129.15
Change
+$1.90 (+1.49%)
Capitalization
55B

MKGAF Merck KGaA Forecast, Technical & Fundamental Analysis

Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare... Show more

MKGAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MKGAF with price predictions
Sep 05, 2025

MKGAF sees its Stochastic Oscillator recovers from oversold territory

On September 03, 2025, the Stochastic Oscillator for MKGAF moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 63 instances where the indicator left the oversold zone. In of the 63 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MKGAF just turned positive on September 05, 2025. Looking at past instances where MKGAF's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MKGAF advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MKGAF as a result. In of 119 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

MKGAF moved below its 50-day moving average on August 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MKGAF crossed bearishly below the 50-day moving average on August 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MKGAF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.704) is normal, around the industry mean (16.681). P/E Ratio (16.808) is within average values for comparable stocks, (74.219). Projected Growth (PEG Ratio) (1.283) is also within normal values, averaging (1.902). Dividend Yield (0.019) settles around the average of (0.031) among similar stocks. P/S Ratio (2.270) is also within normal values, averaging (42.934).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MKGAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MKGAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
MKGAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

MKGAF paid dividends on April 28, 2021

Merck KGaA MKGAF Stock Dividends
А dividend of $1.40 per share was paid with a record date of April 28, 2021, and an ex-dividend date of April 26, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Frankfurter Strasse 250
Phone
+49 6151720
Employees
62908
Web
https://www.emdgroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BSAC25.650.63
+2.52%
Banco Santander-Chile
FEAM3.440.05
+1.47%
5E Advanced Materials Inc.
ANIP95.35-0.65
-0.68%
ANI Pharmaceuticals
BWB16.09-0.47
-2.84%
Bridgewater Bancshares
DRMA5.26-0.24
-4.42%
Dermata Therapeutics Inc

MKGAF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MKGAF has been loosely correlated with MKKGY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKGAF jumps, then MKKGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
+1.49%
MKKGY - MKGAF
49%
Loosely correlated
+1.66%
AQST - MKGAF
19%
Poorly correlated
+7.11%
INDV - MKGAF
17%
Poorly correlated
+1.01%
EVO - MKGAF
17%
Poorly correlated
+3.26%
EBS - MKGAF
16%
Poorly correlated
-0.66%
More

Groups containing MKGAF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
+1.49%
Pharmaceuticals: Generic
industry (222 stocks)
-1%
Poorly correlated
+2.50%